CHINA PHARMA HOLDINGS, INC. (CPHI) Gross margin 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) gross margin by fiscal year — reported gross profit divided by reported revenue.
-3.2%FY2025 · since FY2016: 20.7% → -3.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3.2% | +40.7 pp |
| FY2024 | -43.8% | -39.8 pp |
| FY2023 | -4.0% | +2.1 pp |
| FY2022 | -6.1% | -9.7 pp |
| FY2021 | 3.6% | -14.3 pp |
| FY2020 | 18.0% | +4.4 pp |
| FY2019 | 13.6% | -2.4 pp |
| FY2018 | 16.0% | -2.7 pp |
| FY2017 | 18.7% | -2.0 pp |
| FY2016 | 20.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice